Current Report Filing (8-k)
June 05 2017 - 02:05PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 5, 2017
MEDIFAST, INC.
(Exact name of registrant as specified in
its Charter)
Delaware
|
|
001-31573
|
|
13-3714405
|
(State or other jurisdiction
|
|
(Commission file number)
|
|
(IRS Employer
|
of incorporation)
|
|
|
|
Identification No.)
|
3600 Crondall Lane, Owings Mills,
Maryland 21117
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s telephone number, including
area code:
(410) 581-8042
N/A
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under
the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under
the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 7.01.
|
Regulation FD Disclosure.
|
On June 5, 2017,
Daniel R. Chard, Chief Executive Officer of Medifast, Inc. (the “Company”), will make a presentation at the
Direct Selling Association 2017 Annual Meeting in Orlando, Florida. Mr. Chard will make his presentation at 1:35 EDT. A copy
of the presentation is furnished as Exhibit 99.1 to this Current Report on Form 8-K and will be archived online on the
Investor Relations section of the Company’s website at https://ir.medifastnow.com/ through June 19, 2017.
The information contained
in the presentation is summary information that should be considered in the context of the Company’s filings with the Securities
and Exchange Commission (the “SEC”) and other public announcements the Company may make by press release or otherwise
from time to time. The Company undertakes no duty or obligation to publically update or revise the information in the presentation,
although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing
of other reports or documents with the SEC, through press releases or through other public disclosure.
The information presented
in Item 7.01 of this Current Report on Form 8-K, and Exhibit 99.1, shall not be deemed to be “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities
of that section, unless the Company specifically states that the information is to be considered “filed” under the
Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange
Act.
|
Item 9.01.
|
Financial Statements
and Exhibits.
|
|
99.1
|
Presentation dated June
5, 2017.
|
Signature
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
MEDIFAST, INC.
|
|
|
|
|
|
By:
|
/s/ Jason L. Groves
|
|
|
Jason L. Groves, Esq.
Executive Vice President and General Counsel
|
|
|
|
|
|
Dated: June 5, 2017
|
|
EXHIBIT INDEX
|
99.1
|
Presentation dated June 5, 2017.
|
Medifast (NYSE:MED)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medifast (NYSE:MED)
Historical Stock Chart
From Mar 2023 to Mar 2024